Donata Villari - Publications

Cell-Free Carbonic Anhydrase IX mRNA in Urine as Biomarker for Urogenital Cancers: The Relationship Between Urinary Extracellular RNA and Tumor-Cell-Associated RNA.

Journal: Current issues in molecular biology

Published: October 21, 2024

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

Journal: Cancer chemotherapy and pharmacology

Published: July 31, 2023

Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experience.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 04, 2023

Tyrosine kinase and immune checkpoints inhibitors in favorable risk metastatic renal cell carcinoma: Trick or treat?

Journal: Pharmacology & therapeutics

Published: April 03, 2023

Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?

Journal: International journal of molecular sciences

Published: January 13, 2023

Inflammation in Urological Malignancies: The Silent Killer.

Journal: International journal of molecular sciences

Published: October 17, 2022

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy.

Journal: Medicina (Kaunas, Lithuania)

Published: May 16, 2022

Potential utility of a 4-marker immunohistochemistry panel to predict response to cisplatin-based neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a single-center preliminary experience.

Journal: Minerva urology and nephrology

Published: September 08, 2021

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives.

Journal: Cancers

Published: July 28, 2021

Prostate Cancer Characteristics in Renal Transplant Recipients: A 25-Year Experience From a Single Centre.

Journal: Frontiers in surgery

Published: May 29, 2021

The Impact of Lockdown on Couples' Sex Lives.

Journal: Journal of clinical medicine

Published: February 28, 2021

Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study.

Journal: Urologic oncology

Published: April 29, 2020